Apple Inc. AAPL has launched iOS 18.3, addressing 29 safety vulnerabilities.
What Occurred: The replace addresses a number of safety flaws, with one already being actively exploited.
The exploited vulnerability tracked as CVE-2025-24085, entails a flaw in CoreMedia that might permit a malicious software to realize elevated privileges on the system.
Apple confirmed that this flaw could have been utilized in assaults focusing on earlier iOS variations earlier than iOS 17.2, making the replace notably pressing for customers on older variations.
See Additionally: Apple AirPods With Cameras? Rumors Persist About Subsequent-Gen Options
Different Key Vulnerabilities Addressed In iOS 18.3
The replace fixes two vital Kernel bugs that might permit malicious apps to realize root privileges or execute code with Kernel-level entry. These vulnerabilities tracked as CVE-2025-24107, goal the core of iOS, making them crucial to patch.
Apple additionally addressed a number of WebKit points, the engine behind Safari. One WebKit bug might permit command injection, whereas one other might end in surprising app crashes or code execution. An AirPlay vulnerability was additionally patched.
Moreover, a bug in Passkeys was resolved, which beforehand allowed unauthorized Bluetooth entry by way of malicious apps.
Subscribe to the Benzinga Tech Traits publication to get all the newest tech developments delivered to your inbox.
System Compatibility
iOS 18.3 is offered for a variety of Apple units.
How To Replace Your iPhone
To replace your system to iOS 18.3, go to Settings > Basic > Software program Replace. Obtain and set up the replace to make sure your iPhone is safe.
Why It Issues: Apple reportedly plans to launch the iOS 18.4 replace in April. As per experiences, iOS 18.4 is predicted to convey enhancements comparable to a better Siri, expanded language help for Apple Intelligence, and improved performance for apps like Residence.
Picture courtesy: Shutterstock
Try extra of Benzinga’s Client Tech protection by following this hyperlink.
Learn Subsequent:
Disclaimer: This content material was partially produced with the assistance of Benzinga Neuro and was reviewed and printed by Benzinga editors.
Market Information and Information delivered to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.